{
  "report_rows": [
    {
      "kpi": "Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$905M vs. cons $876M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "ARR (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$1,640M vs. cons $1,589M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. EBITDA Margin (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~25.3% vs. cons 25.2%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Revenue (FY)",
      "prediction": "BETTER",
      "answer": "guide ~$3,740M midpoint vs. cons $3,674M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Adj. EBITDA Margin (FY)",
      "prediction": "UNCHANGED",
      "answer": "guide ~25.5% vs. cons 25.6%",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY 2026 FCF (FY)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$450M reaffirmed vs. cons $457M",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 4.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 8.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 sell-side raises Q3/Q4 on FY guide raise; partial reset in run-in supports follow-through but absolute multiple caps upside vs. historical Archetype A median",
  "day5_confidence": "MEDIUM"
}